Coronavirus

Good News! Oxford Vaccine Shows Immune Response

By
OB Bureau

London: The COVID-19 experimental vaccine by AstraZeneca and UK’s Oxford University has been found to be safe and has produced an immune response in the early clinical trials.

The vaccine, named ChAdOx1 nCoV-19, didn’t result in any serious side effects and produced antibody and T-cell immune responses in the 1,077 people it was tried on, according to results published in The Lancet medical journal.

Around 70 per cent of the people developed fever and headache, which were managed by paracetamol.

“We hope this means the immune system will remember the virus so that our vaccine will protect people for an extended period,” Andrew Pollard of the University of Oxford said.

“However, we need more research before we can confirm the vaccine effectively protects against SARS-CoV-2 (COVID-19) infection, and for how long any protection lasts,” he added.

This vaccine is made from a genetically engineered virus that causes the common cold in chimpanzees. It is heavily modified so that it can’t cause infections in humans and will make it “look” more like coronavirus, the BBC reported. This was done by transferring the genetic instructions of the coronavirus’ “spike protein” to the vaccine. COVID-19 uses this spike protein to invade human cells. Hence, the vaccine resembles the coronavirus and our immune system learns how to attack it.

What’s Next?

The main purpose of this phase was safety. In the next phase, more than 10,000 people will take part in the UK followed by a large trial involving 30,000 people in the US, 2,000 in South Africa, and 5,000 in Brazil.

The vaccine could probably be available at the end of this year, UK Prime Minister Boris Johnson has said.

AstraZeneca is among the leading vaccine developers who are in mid and late-stage trials.

US-based Moderna is believed to be currently leading in the development. China’s Sinovac Biotech is also at the forefront.

AstraZeneca has said it will not seek to profit from the vaccine during the pandemic.

 

OB Bureau

Recent Posts

India Makes Formal Bid To Host 2036 Olympics, Sends Letter Of Intent To IOC: Reports

New Delhi: India has taken the first step in its attempt to host the 2036…

November 5, 2024

Bullets Fired At Nandan Kanan Express Train In Odisha’s Bhadrak! Probe Launched

Bhadrak: Amid allegations that bullets were fired at the Nandan Kanan Express train near Charampa…

November 5, 2024

Odisha Health Dept Official Arrested For Carrying Rs 2.8 Lakh ‘Ill-Gotten’ Cash

Bhubaneswar: Odisha Vigilance on Tuesday arrested senior assistant in Additional District Public Health Office (Family…

November 5, 2024

Rain May Lash Bhubaneswar & 4 Odisha Dists By 6PM Today; Dry Spell From Nov 8

Bhubaneswar: The regional centre of India Meteorological Department (IMD) has sounded yellow warning for four…

November 5, 2024

Odisha Deputy CM Holds Talks With Indian Envoy In London On Measures To Boost Tourism

Bhubaneswar: Odisha’s Deputy Chief Minister Pravati Parida held a meeting with the Indian High Commissioner…

November 5, 2024

India To Celebrate 125th Birth Anniv Of Odisha’s First CM Harekrushna Mahatab, Informs Mohan Majhi

Bhubaneswar: Chief Minister Mohan Charan Majhi on Tuesday informed about the central government's plans for…

November 5, 2024

Cracks On Puri Jagannath Temple’s Meghanada Pacheri: Odisha BJP Blames Previous BJD Govt

Bhubaneswar: Amid a brouhaha over cracks detected on the ‘Meghanada Pacheri’ surrounding Shree Jatannath Temple…

November 5, 2024

Daughter’s Name Can’t Be Deleted From List Of Family Members Eligible For Govt Employee’s Pension

New Delhi: In a recently released guidelines, the Department of Pension and Pensioners’ Welfare (DoPPW)…

November 5, 2024